MJT & Associates Financial Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.81K Buy
31
+21
+210% +$1.17K ﹤0.01% 377
2026
Q2
$545 Buy
+10
New +$487 ﹤0.01% 434

Other funds holding EXEL

MJT & Associates Financial Advisory's EXEL Position: Q3 2026 in Review

MJT & Associates Financial Advisory increased its Exelixis (EXEL) stake by 210% in Q3 2026, buying an estimated $1.17K and bringing the position to 31 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

MJT & Associates Financial Advisory first reported a position in EXEL in Q2 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • MJT & Associates Financial Advisory held 31 shares of Exelixis worth $1.81K as of Q3 2026.
  • MJT & Associates Financial Advisory bought 21 Exelixis shares in Q3 2026, an estimated $1.17K.
  • Exelixis made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #377 holding.
  • MJT & Associates Financial Advisory first reported a position in Exelixis in Q2 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.